Cuvrior Tablet, Film Coated
Product Images NDC 81802-001

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cuvrior (NDC 81802-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Orphalan Sa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cuvrior 01)

Chemical structure of trientine tetrahydrochloride, the active ingredient in CUVRIOR 300 mg film-coated tablets. The diagram shows the molecular arrangement including amino groups and hydrochloride components.*

FDA Label Image

Principal Display Panel (72 Tablet Blister Pack Carton)

Packaging label for CUVRIOR (trientine tetrahydrochloride) tablets, 300 mg. Film-coated oral tablets are supplied by Orphalan SA. The label indicates a carton containing 72 tablets (9 cartons of 8 tablets). The label includes storage instructions, manufacturer contact details, and a space for attaching a lot number and expiry date label. Product is Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.